R R

What Is Nplate?

Nplate is a prescription medication containing romiplostim, a thrombopoietin receptor agonist that stimulates platelet production. It is used for certain patients with immune thrombocytopenia (ITP) who have not responded adequately to specified previous treatments. Nplate is also approved to increase survival after acute exposure to myelosuppressive radiation doses in adults and children, including full-term newborns. It is administered by subcutaneous injection under medical supervision.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Nplate?

Nplate is a prescription medication containing romiplostim, a thrombopoietin receptor agonist that stimulates platelet production. It is used for certain patients with immune thrombocytopenia (ITP) who have not responded adequately to specified previous treatments. Nplate is also approved to increase survival after acute exposure to myelosuppressive radiation doses in adults and children, including full-term newborns. It is administered by subcutaneous injection under medical supervision.

read more about nplate ...

Copy this HTML:

Copy HTML Copied!

How Does Nplate Work?

Nplate activates thrombopoietin receptors on cells involved in platelet production within the bone marrow. This stimulates the development of megakaryocytes, which release platelets into the bloodstream. Increasing platelet counts can reduce bleeding risk in patients with immune thrombocytopenia. Nplate does not directly stop active bleeding or cure the underlying immune disorder. In radiation exposure, stimulation of platelet production supports recovery from damage to blood-forming tissues.

Who Can Receive Nplate Treatment?

Nplate is approved for adults with immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It is also approved for children aged one year and older with ITP lasting at least six months who have responded inadequately to these treatments. Another indication involves acute radiation syndrome following myelosuppressive radiation exposure. Nplate is not indicated for thrombocytopenia caused by myelodysplastic syndromes or for all causes of low platelet counts.

How Is Nplate Administered?

For immune thrombocytopenia, Nplate is injected beneath the skin once weekly. Treatment generally begins at 1 microgram per kilogram of body weight, with dose adjustments based on platelet counts. The goal is to maintain enough platelets to reduce bleeding risk rather than normalize the platelet count. The maximum weekly dose for ITP is 10 micrograms per kilogram. Platelet levels are monitored frequently during treatment and after discontinuation. Radiation exposure follows a separate single-dose regimen.

What Are the Side Effects and Warnings of Nplate?

Common adverse effects in patients with immune thrombocytopenia include headache, joint pain, dizziness, insomnia, and muscle discomfort. Serious risks include blood clots, excessive platelet increases, and worsening thrombocytopenia after treatment stops. Nplate can also increase bone marrow reticulin, requiring evaluation in selected cases. Patients with liver disease or risk factors for thrombosis need careful monitoring. New chest pain, breathing difficulties, neurological symptoms, or unusual bleeding require prompt medical attention.

Common Questions About Nplate

Does Nplate increase platelet counts?

Yes. Nplate stimulates thrombopoietin receptors and increases platelet production in the bone marrow.

Is Nplate a treatment for immune thrombocytopenia?

Yes. Nplate is approved for certain adults and children with ITP who have not responded adequately to specified previous treatments.

How often is Nplate administered?

For ITP, Nplate is generally administered once weekly by subcutaneous injection. Dosage adjustments depend on platelet count monitoring.

Can Nplate cause blood clots?

Yes. Increased platelet counts associated with Nplate can contribute to blood clot formation. Treatment aims to reduce bleeding risk without unnecessarily elevating platelet counts.

References

DailyMed - NPLATE (romiplostim) injection, powder, for solution. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c45f9a58-37c1-4f76-8e36-97d38c577037. Date Accessed October 19, 2026.

Romiplostim. Drugs and Lactation Database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK565974/. Date Accessed October 19, 2026.

Romiplostim. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/drugs/romiplostim. Date Accessed October 19, 2026.

Romiplostim. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/romiplostim. Date Accessed October 19, 2026.

Romiplostim Injection. MedlinePlus. https://medlineplus.gov/druginfo/meds/a609008.html. Date Accessed October 19, 2026.